EuPRAXIA Preparatory Phase Project

EuPRAXIA预备阶段项目

• 批准号: 10040004
• 金额: $ 3.29万
• 依托单位: STFC - LABORATORIES
• 依托单位国家: 英国
• 项目类别: EU-Funded
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10040004
• 关键词: EuPRAXIA; Preparatory; Phase; Project

EuPRAXIA is a distributed, compact and innovative accelerator facility based on plasma technology. It has been selected for the 2021 Update of the ESFRI Roadmap. In its first phase, its consortium of 51 institutes and industry partners will construct an electron-beamdriven plasma accelerator in the metropolitan area of Rome, thus bringing innovation, potential for spin-off companies, state-of-the art scientific applications and a vibrant international user community to the middle of Italy. In its second phase, EuPRAXIA will build one laser-driven plasma accelerator at a site to be chosen between several options in Europe. EuPRAXIA will serve users in ultra-fast science, e.g. on high-resolution medical imaging, deeply penetrating positron annihilation spectroscopy for materials and with Europe’s most southern free-electron laser (FEL). It will offer fascinating capabilities for research on biomolecules, viruses and microscopic processes. EuPRAXIA will thus be a transformative step in the development of ultra-compact accelerators and applications. The Preparatory Phase project EuPRAXIA-PP will prepare its full implementation

EuPRAXIA是一个基于等离子体技术的分布式、紧凑型和创新型加速器设施。它已被选为ESFRI路线图的2021年更新。在第一阶段，其51个研究所和行业伙伴组成的联合体将在罗马大都市区建造一个电子束驱动等离子体加速器，从而将创新、衍生公司的潜力、最先进的科学应用和充满活力的国际用户社区带到意大利中部。在第二阶段，EuPRAXIA将在欧洲的几个选择中选择一个地点建造一个激光驱动的等离子体加速器。EuPRAXIA将为超快科学领域的用户提供服务，例如高分辨率医学成像、材料的深穿透正电子湮没光谱以及欧洲最南端的自由电子激光器（FEL）。它将为生物分子、病毒和微观过程的研究提供迷人的能力。因此，EuPRAXIA将成为超紧凑型加速器和应用开发的变革性一步。准备阶段项目EuPRAXIA-PP将准备全面实施